Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Tuesday, December 8, 2009, 7:41PM ET - U.S. Markets Closed. Dow Down 1.00% Nasdaq Down 0.76%
Caliper Life Sciences, Inc. (CALP)At 3:58PM ET: 2.46  Down 0.01 (0.40%)  
MORE ON CALP
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Caliper Life Sciences, Inc.
68 Elm Street
Hopkinton, MA 01748
United States - Map
Phone: 508-435-9500
Fax: 508-435-3439
Web Site: http://www.caliperls.com

DETAILS 
Index Membership:N/A
Sector:Technology
Industry:Scientific & Technical Instruments
Full Time Employees:489

BUSINESS SUMMARY 
Caliper Life Sciences, Inc. develops and sells products and services to pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide. Its integrated systems consist of instruments, software and reagents, laboratory automation tools, and assay and discovery services. The company offers a portfolio of molecular imaging, microfluidics, automation and liquid handling technologies, and scientific applications to address various limitations in the drug discovery and development process. Its products include IVIS Imaging Systems and Living Image Software, an integrated optical molecular imaging solution; Light-Producing Cells and Microorganisms to analyze the spread and treatment of cancer and infectious diseases, as well as to study immunology; Light Producing Transgenic Animal models to analyze gene expression, protein activity, and disease progression; and luciferin, a chemical compound to produce bioluminescence, and VivoFluor fluorescent labeling kits for fluorescent imaging. The company’s products also comprise LabChip 3000 Drug Discovery System, which produces data that minimizes false positives and false negatives, and detects weak inhibitors; LabChip EZ Reader, EZ Reader II, and ProfilerPro Kits; Caliper Sciclone that incorporates automated microplate carriers; Zephyr, a liquid handling instrument; staccato automated workstations for drug discovery, genomics, proteomics, and drug development laboratories; Twister I and II, which automate the movement of microplates; MultiDose G3, an automated dissolution testing system; and active pharmaceutical ingredient workstation. In addition, it offers contract research and transgenic animal services, drug discovery and development services, product support, and validation services. Caliper Life Sciences sells its products through direct sales force and a network of distributors. The company was founded in 1995 and is headquartered in Hopkinton, Massachusetts.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Caliper Life Sciences, Inc.


    CORPORATE GOVERNANCE 
    Caliper Life Sciences, Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Dec-09 is better than 36.7% of CGQ Universe companies and 15.9% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Dr. E. Kevin Hrusovsky , 47
    Chief Exec. Officer, Pres and Exec. Director
    N/A N/A
    Mr. Peter F. McAree , 44
    Chief Financial Officer and Sr. VP
    N/A N/A
    Mr. Stephen E. Creager , 55
    Sr. VP, Sec. and Gen. Counsel
    N/A N/A
    Dr. David M. Manyak Ph.D., 56
    Exec. VP of Drug Discovery Services
    $ 261.00KN/A
    Mr. William C. Kruka , 48
    Sr. VP of Corp. Devel.
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis